Panel recommends approval of new COPD treatment

09/10/2013 | Reuters

An FDA panel voted 11-2 to recommend approval of GlaxoSmithKline's inhaled drug Anoro Ellipta for patients with chronic obstructive pulmonary disease. The drug is a combination of vilanterol and umeclidinium. Some members of the panel cited safety concerns including data that suggest a possible link between the drug and heart problems.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY